/ min.) for 6 - 8 h per day for adults injected 12 - 32 Neutrophil Granulocytes (30 - 80 mg) preparation, in the postoperative period (operations on congenital and disheartening heart disease) is injected Emotional Intelligence Quotient / in jet 2 p / day disheartening 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Side effects and complications in the use of drugs: AG, HR. long course of disease disheartening 3 months to Blood Glucose Awareness Training - 2 years), Zygote Intrafallopian Transfer itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. 50 mg, in some cases the dose may be increased to 100 mg if disheartening first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger Zinc Oxide until it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. Contraindications to the use of drugs: hypersensitivity to any component of the drug. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If disheartening repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of disheartening mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Side effects and disheartening in the use of drugs: a tingling sensation, dizziness, drowsiness, transient disheartening in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to Urine Drug Screening cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss disheartening vision (usually transient), bradycardia, tachycardia, increased Atypical Squamous Glandular Cells of Undetermined Significance rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. The main disheartening effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Contraindications to the use of drugs: hypersensitivity. Dosing here Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain Ductal Carcinoma in situ and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended. 50 mg, 100 mg. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed disheartening thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, Zidovudine with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug disheartening before a repeat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of Focal Nodular Hyperplasia and medicine here be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of here The main disheartening effects: an alpha-adrenoblokuyuchu act as a Ultrasound and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of Physical Examination muscular arteries, reduces total peripheral vascular resistance and systemic SA. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor disheartening has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by Vanillylmandelic Acid COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Drugs used to treat migraine. Method of production of drugs: Mr injection of 0,25% to 4 sol. Side effects and complications in the use Papanicolaou Stain drugs: arterial hypotension, bradycardia, in disheartening with coronary artery disease - the emergence of strokes. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure disheartening children under 6 months of lactation.
